ELEV logo

Elevation Oncology (ELEV) EBIT

Annual EBIT

-$41.47 M
+$52.08 M+55.67%

December 31, 2023


Summary


Performance

ELEV EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELEVprofitabilitymetrics:

Quarterly EBIT

-$13.23 M
-$2.27 M-20.67%

September 30, 2024


Summary


Performance

ELEV Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELEVprofitabilitymetrics:

TTM EBIT

-$43.14 M
-$2.31 M-5.65%

September 30, 2024


Summary


Performance

ELEV TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELEVprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ELEV EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.7%0.0%0.0%
3 y3 years-140.1%+24.6%+53.9%
5 y5 years-+24.6%+53.9%

ELEV EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.4%+55.7%-45.7%+65.7%-34.6%+53.9%
5 y5-year-140.1%+55.7%-575.3%+65.7%-2102.3%+53.9%
alltimeall time-140.1%+55.7%-575.3%+65.7%-2102.3%+53.9%

Elevation Oncology EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.23 M(+20.7%)
-$43.14 M(+5.7%)
Jun 2024
-
-$10.96 M(+11.1%)
-$40.83 M(+2.8%)
Mar 2024
-
-$9.87 M(+8.7%)
-$39.70 M(-4.3%)
Dec 2023
-$41.47 M(-55.7%)
-$9.08 M(-16.8%)
-$41.47 M(-16.9%)
Sep 2023
-
-$10.92 M(+11.0%)
-$49.94 M(-35.6%)
Jun 2023
-
-$9.83 M(-15.5%)
-$77.55 M(-11.7%)
Mar 2023
-
-$11.64 M(-33.7%)
-$87.83 M(-6.1%)
Dec 2022
-$93.56 M
-$17.54 M(-54.5%)
-$93.56 M(+9.2%)
Sep 2022
-
-$38.53 M(+91.6%)
-$85.64 M(+44.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$20.11 M(+15.8%)
-$59.38 M(+34.0%)
Mar 2022
-
-$17.37 M(+80.5%)
-$44.33 M(+38.3%)
Dec 2021
-$32.05 M(+85.5%)
-$9.62 M(-21.6%)
-$32.05 M(+2.4%)
Sep 2021
-
-$12.28 M(+142.7%)
-$31.31 M(+42.0%)
Jun 2021
-
-$5.06 M(-0.5%)
-$22.04 M(+8.0%)
Mar 2021
-
-$5.09 M(-42.8%)
-$20.40 M(+18.1%)
Dec 2020
-$17.28 M
-$8.89 M(+195.1%)
-$17.28 M(+105.9%)
Sep 2020
-
-$3.01 M(-11.9%)
-$8.39 M(+56.0%)
Jun 2020
-
-$3.42 M(+74.5%)
-$5.38 M(+174.5%)
Mar 2020
-
-$1.96 M
-$1.96 M

FAQ

  • What is Elevation Oncology annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Elevation Oncology?
  • What is Elevation Oncology annual EBIT year-on-year change?
  • What is Elevation Oncology quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Elevation Oncology?
  • What is Elevation Oncology quarterly EBIT year-on-year change?
  • What is Elevation Oncology TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Elevation Oncology?
  • What is Elevation Oncology TTM EBIT year-on-year change?

What is Elevation Oncology annual earnings before interest & taxes?

The current annual EBIT of ELEV is -$41.47 M

What is the all time high annual EBIT for Elevation Oncology?

Elevation Oncology all-time high annual earnings before interest & taxes is -$17.28 M

What is Elevation Oncology annual EBIT year-on-year change?

Over the past year, ELEV annual earnings before interest & taxes has changed by +$52.08 M (+55.67%)

What is Elevation Oncology quarterly earnings before interest & taxes?

The current quarterly EBIT of ELEV is -$13.23 M

What is the all time high quarterly EBIT for Elevation Oncology?

Elevation Oncology all-time high quarterly earnings before interest & taxes is -$1.96 M

What is Elevation Oncology quarterly EBIT year-on-year change?

Over the past year, ELEV quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Elevation Oncology TTM earnings before interest & taxes?

The current TTM EBIT of ELEV is -$43.14 M

What is the all time high TTM EBIT for Elevation Oncology?

Elevation Oncology all-time high TTM earnings before interest & taxes is -$1.96 M

What is Elevation Oncology TTM EBIT year-on-year change?

Over the past year, ELEV TTM earnings before interest & taxes has changed by $0.00 (0.00%)